The Comparative Oncology Trials Consortium: Using Spontaneously Occurring Cancers in Dogs to Inform the Cancer Drug Development Pathway.

The article offers information about the Comparative Oncology Trials Consortium (COTC) of the National Cancer Institute (NCI) in the U.S. It notes that COTC offers infrastructure and resources which are necessary in integrating cancer models into the development of cancer drugs, imaging techniques and devices. It is designed to execute clinical trials in dogs suffering from cancer. It also develops an electronic reporting system for data collection and provide study result monitoring.